AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly resultsNearly a decade after AstraZenecafended off a hostile takeover approach from US rival Pfizer, the British drug firm has overtaken the Viagra maker in terms of market value, marking a significant moment in its turnaround – and for UK plc.In a week when AstraZeneca and Britain ’s second-biggest pharma firm GSK release their latest quarterly results and the main industry body, the Association of the British Pharmaceutical Industry holds its annual conference, all eyes will be on what pharma executives say about the UK as a place to operate and invest in.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: AstraZeneca GlaxoSmithKline Pharmaceuticals industry Business London Stock Exchange Pfizer Science UK news Source Type: news